MACDONALD, LYNN,MURPHY, ANDREW J.,GURER, CAGAN,KYRATSOUS, CHRISTOS
申请号：
CA2980771
公开号：
CA2980771A1
申请日:
2016.04.06
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
Disclosed herein are non-human animals (e.g., rodents, e.g., mice or rats) genetically engineered to express a humanized T cell co-receptor (e.g., humanized CD4 and/or CD8 (e.g., CD8a and/or CD8ß )), a human or humanized T cell receptor (TCR) comprising a variable domain encoded by at least one human TCR variable region gene segment and/or a human or humanized major histocompatibility complex that binds the humanized T cell co-receptor (e.g., human or humanized MHC II (e.g., MHC II a and/or MHC II ß chains) and/or MHC I (e.g., MHC I a ) respectively, and optionally human or humanized ß2 microglobulin). Also provided are embryos, tissues, and cells expressing the same. Methods for making a genetically engineered animal that expresses at least one humanized T cell co-receptor (e.g., humanized CD4 and/or CD8), at least one humanized MHC that associates with the humanized T cell co-receptor (e.g., humanized MHC II and/or MHC I, respectively) and/or the humanized TCR are also provided. Methods for using the genetically engineered animals that mount a substantially humanized T cell immune response for developing human therapeutics are also provided.
